Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 15 studies | 28% ± 10% | |
endothelial cell | 13 studies | 29% ± 10% | |
glutamatergic neuron | 11 studies | 34% ± 22% | |
mesothelial cell | 8 studies | 33% ± 11% | |
neuron | 7 studies | 37% ± 14% | |
interneuron | 7 studies | 32% ± 17% | |
endothelial cell of vascular tree | 7 studies | 44% ± 17% | |
GABAergic neuron | 6 studies | 41% ± 15% | |
naive B cell | 5 studies | 21% ± 4% | |
capillary endothelial cell | 4 studies | 34% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 7% | |
endothelial cell of artery | 3 studies | 24% ± 4% | |
vein endothelial cell | 3 studies | 28% ± 4% | |
oligodendrocyte | 3 studies | 21% ± 5% | |
myoepithelial cell | 3 studies | 22% ± 6% | |
enteroendocrine cell | 3 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 33% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 3325.36 | 2609 / 2642 | 99% | 40.83 | 701 / 705 |
thymus | 100% | 2408.10 | 653 / 653 | 98% | 38.81 | 593 / 605 |
ovary | 98% | 1377.94 | 177 / 180 | 92% | 46.01 | 396 / 430 |
kidney | 98% | 1000.90 | 87 / 89 | 92% | 44.45 | 828 / 901 |
breast | 95% | 1559.39 | 438 / 459 | 87% | 15.32 | 978 / 1118 |
prostate | 96% | 1259.51 | 234 / 245 | 61% | 7.66 | 306 / 502 |
lung | 81% | 1118.59 | 469 / 578 | 72% | 14.45 | 831 / 1155 |
bladder | 100% | 2103.62 | 21 / 21 | 51% | 9.98 | 256 / 504 |
intestine | 85% | 688.92 | 821 / 966 | 59% | 10.18 | 312 / 527 |
uterus | 98% | 2266.31 | 167 / 170 | 43% | 8.90 | 199 / 459 |
skin | 42% | 294.71 | 759 / 1809 | 84% | 36.75 | 398 / 472 |
stomach | 52% | 363.69 | 187 / 359 | 65% | 9.60 | 187 / 286 |
esophagus | 65% | 599.58 | 933 / 1445 | 48% | 7.92 | 87 / 183 |
pancreas | 16% | 80.30 | 54 / 328 | 88% | 19.68 | 156 / 178 |
blood vessel | 99% | 2398.45 | 1322 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 18% | 138.25 | 47 / 258 | 73% | 51.99 | 169 / 230 |
adipose | 88% | 1733.21 | 1063 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 30.31 | 22 / 29 |
tonsil | 0% | 0 | 0 / 0 | 71% | 21.74 | 32 / 45 |
eye | 0% | 0 | 0 / 0 | 56% | 11.33 | 45 / 80 |
heart | 52% | 488.85 | 450 / 861 | 0% | 0 | 0 / 0 |
spleen | 42% | 229.86 | 102 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 21% | 486.83 | 197 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 17% | 1.74 | 70 / 406 |
muscle | 2% | 8.84 | 14 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002695 | Biological process | negative regulation of leukocyte activation |
GO_0032793 | Biological process | positive regulation of CREB transcription factor activity |
GO_0071636 | Biological process | positive regulation of transforming growth factor beta production |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0043031 | Biological process | negative regulation of macrophage activation |
GO_1904465 | Biological process | negative regulation of matrix metallopeptidase secretion |
GO_0150077 | Biological process | regulation of neuroinflammatory response |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_2000405 | Biological process | negative regulation of T cell migration |
GO_0050776 | Biological process | regulation of immune response |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0150079 | Biological process | negative regulation of neuroinflammatory response |
GO_0150074 | Biological process | positive regulation of protein-glutamine gamma-glutamyltransferase activity |
GO_0150072 | Biological process | positive regulation of arginase activity |
GO_1905522 | Biological process | negative regulation of macrophage migration |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0043025 | Cellular component | neuronal cell body |
GO_0043005 | Cellular component | neuron projection |
GO_0009986 | Cellular component | cell surface |
GO_0044297 | Cellular component | cell body |
GO_0030424 | Cellular component | axon |
GO_0086080 | Molecular function | protein binding involved in heterotypic cell-cell adhesion |
GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
GO_0140081 | Molecular function | glycosylated region protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CD200 |
Protein name | OX-2 membrane glycoprotein (CD antigen CD200) CD200 molecule |
Synonyms | MOX1 My033 MOX2 |
Description | FUNCTION: Costimulates T-cell proliferation. May regulate myeloid cell activity in a variety of tissues. |
Accessions | U3KQG5 ENST00000473539.5 [P41217-3] ENST00000478595.1 ENST00000606471.5 U3KQQ2 ENST00000383681.7 F8WEX3 F8W7G1 F8WC99 ENST00000315711.12 [P41217-2] ENST00000607597.1 ENST00000498096.5 P41217 |